Increased colonic K+ excretion through inhibition of the H,K-ATPase type 2 helps reduce plasma K+ level in a murine model of nephronic reduction
Abstract Hyperkalemia is frequently observed in patients at the end-stage of chronic kidney disease (CKD), and has possible harmful consequences on cardiac function. Many strategies are currently used to manage hyperkalemia, one consisting of increasing fecal K+ excretion through the administration...
Guardado en:
Autores principales: | Christine Walter, Chloé Rafael, Anthony Genna, Stéphanie Baron, Gilles Crambert |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/95044e6a4b6241d28ab66e86aba5a480 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Abnormal Na-K-ATPase activity in erythrocytes from patients with diabetes mellitus
por: Z M Shamansurova, et al.
Publicado: (2009) -
Identification of Na+/K+-ATPase inhibition-independent proarrhythmic ionic mechanisms of cardiac glycosides
por: Cai Hong Koh, et al.
Publicado: (2017) -
Role of adipocyte Na,K-ATPase oxidant amplification loop in cognitive decline and neurodegeneration
por: Komal Sodhi, et al.
Publicado: (2021) -
The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion
por: Kazi Mirajul Hoque, et al.
Publicado: (2020) -
The cryo-EM structure of gastric H+,K+-ATPase with bound BYK99, a high-affinity member of K+-competitive, imidazo[1,2-a]pyridine inhibitors
por: Kazuhiro Abe, et al.
Publicado: (2017)